![TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein | Journal of Virology TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein | Journal of Virology](https://journals.asm.org/cms/10.1128/JVI.00088-17/asset/066340d6-00a7-4426-ab28-1787fcdc6d19/assets/graphic/zjv9991825370003.jpeg)
TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein | Journal of Virology
![Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment | Chemical Research in Toxicology Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment | Chemical Research in Toxicology](https://pubs.acs.org/cms/10.1021/tx500345j/asset/images/large/tx-2014-00345j_0003.jpeg)
Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment | Chemical Research in Toxicology
![PDF) Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis PDF) Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis](https://i1.rgstatic.net/publication/269174783_Visual_outcomes_of_pars_plana_vitrectomy_with_epiretinal_membrane_peel_in_patients_with_uveitis/links/5a66f849aca2720ba6b03162/largepreview.png)
PDF) Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis
![Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment | Chemical Research in Toxicology Defining Molecular Initiating Events in the Adverse Outcome Pathway Framework for Risk Assessment | Chemical Research in Toxicology](https://pubs.acs.org/cms/10.1021/tx500345j/asset/images/large/tx-2014-00345j_0005.jpeg)